GIST
Clinical trials for GIST explained in plain language.
Never miss a new study
Get alerted when new GIST trials appear
Sign up with your email to follow new studies for GIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stomach tumor battle: which endoscopic method wins?
Disease control Recruiting nowThis study compares two endoscopic procedures—EFTR and STER—for removing small gastric GISTs (a type of stomach tumor). About 136 adults with tumors 1.0–3.5 cm will be randomly assigned to one method. The goal is to see which technique removes the entire tumor more completely and…
Matched conditions: GIST
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
New hope for kids with Hard-to-Treat tumors: targeted radiation therapy trial opens
Disease control Recruiting nowThis study tests a radioactive drug called Lu-177 edotreotide in children aged 2 to 17 with tumors that have a specific marker (SSTR). The goal is to find the right dose and check if it is safe. About 20 children whose tumors came back or did not respond to prior treatment will t…
Matched conditions: GIST
Phase: PHASE1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New combo therapy targets advanced GIST in early trial
Disease control Recruiting nowThis study tests a new drug called DCC-3116 combined with other cancer treatments for people with advanced GIST (a type of stomach or bowel cancer). The goal is to find safe doses and see if the combination shrinks tumors. About 94 adults whose cancer has worsened after standard …
Matched conditions: GIST
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New combo therapy aims to shrink hard-to-treat gut tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug, KQB198, to the standard cancer drug imatinib is safe and works better for people with advanced gastrointestinal stromal tumor (GIST). About 46 adults with a specific gene mutation (KIT or PDGFRA) will receive the combination a…
Matched conditions: GIST
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for stomach cancer patients Who've run out of options?
Disease control Recruiting nowThis study tests the drug lenvatinib in people with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to three standard treatments. The goal is to see if lenvatinib can shrink or stabilize the tumors and to check for side effects. About 48 adults will t…
Matched conditions: GIST
Phase: PHASE1, PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Hunt for hidden cancer genes in families
Knowledge-focused Recruiting nowThis research study aims to discover new genes that may increase the risk of childhood cancer. Researchers will collect blood samples and health information from 1,500 people in families where cancer clusters. The goal is to build a registry and sample bank to help future diagnos…
Matched conditions: GIST
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC